| Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma P Caro, AU Kishan, E Norberg, IA Stanley, B Chapuy, SB Ficarro, K Polak, ... Cancer cell 22 (4), 547-560, 2012 | 548 | 2012 |
| 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging … J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ... The Lancet Oncology 20 (9), 1286-1294, 2019 | 417 | 2019 |
| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 400 | 2019 |
| Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019 | 323 | 2019 |
| Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 322 | 2018 |
| 68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage … J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ... Journal of Nuclear Medicine 59 (2), 230-237, 2018 | 282 | 2018 |
| Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... JAMA network open 2 (2), e188006-e188006, 2019 | 278 | 2019 |
| A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER) LF Valle, EJ Lehrer, D Markovic, D Elashoff, R Levin-Epstein, RJ Karnes, ... European urology 80 (3), 280-292, 2021 | 222 | 2021 |
| NCCN GuidelinesŪ insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022 | 216 | 2022 |
| Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology CK Glide-Hurst, P Lee, AD Yock, JR Olsen, M Cao, F Siddiqui, W Parker, ... International Journal of Radiation Oncology* Biology* Physics 109 (4), 1054-1075, 2021 | 210 | 2021 |
| Prostate cancer radiation therapy recommendations in response to COVID-19 NG Zaorsky, BY James, SM McBride, RT Dess, WC Jackson, BA Mahal, ... Advances in radiation oncology 5, 26-32, 2020 | 188 | 2020 |
| Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial AU Kishan, TM Ma, JM Lamb, M Casado, H Wilhalme, DA Low, K Sheng, ... JAMA oncology 9 (3), 365-373, 2023 | 162 | 2023 |
| A systematic review of the evidence for the decipher genomic classifier in prostate cancer NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ... European urology 79 (3), 374-383, 2021 | 150 | 2021 |
| Online adaptive radiation therapy: implementation of a new process of care J Lamb, M Cao, A Kishan, N Agazaryan, DH Thomas, N Shaverdian, ... Cureus 9 (8), 2017 | 135 | 2017 |
| Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings: a prospective single-center study I Sonni, M Eiber, WP Fendler, RM Alano, SS Vangala, AU Kishan, ... Journal of Nuclear Medicine 61 (8), 1153-1160, 2020 | 126 | 2020 |
| Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis AU Kishan, T Shaikh, PC Wang, RE Reiter, J Said, G Raghavan, ... European urology 71 (5), 766-773, 2017 | 113 | 2017 |
| Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis AU Kishan, Y Sun, H Hartman, TM Pisansky, M Bolla, A Neven, A Steigler, ... The lancet oncology 23 (2), 304-316, 2022 | 109 | 2022 |
| Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis LA Gharzai, R Jiang, D Wallington, G Jones, S Birer, N Jairath, ... The Lancet Oncology 22 (3), 402-410, 2021 | 100 | 2021 |
| Lipids and age-related macular degeneration AU Kishan, BS Modjtahedi, EN Martins, SP Modjtahedi, LS Morse Survey of ophthalmology 56 (3), 195-213, 2011 | 99 | 2011 |
| Image-guided radiotherapy for prostate cancer A Dang, PA Kupelian, M Cao, N Agazaryan, AU Kishan Translational andrology and urology 7 (3), 308, 2018 | 98 | 2018 |
